Concepedia
Statistics
Publications
9
Citations
785
H-Index
Active since
1984
Affiliations
Ambrx (United States)(Current)
Torrey Pines Institute For Molecular Studies
Scripps Research Institute
Merck & Co., Inc., Rahway, NJ, USA (United States)
Nick Knudsen is an author at Ambrx (United States) specializing in medicine, medicinal chemistry, and drug discovery.
Top concepts
MedicineDrug DiscoveryMedicinal ChemistryImmunologyPharmacologyImmunotherapyAntibody EngineeringOncologyBiochemistryCell Biology
Publications per year
1984–2024
Optimized clinical performance of growth hormone with an expanded genetic code
Ho Cho, T. Sheidy Daniel, Ying J. Buechler et al. · Proceedings of the National Academy of Sciences · 2011 · 197 citations · Full text
Human Growth, Genetics, Glycobiology +20
ARX788, a Site-specific Anti-HER2 Antibody–Drug Conjugate, Demonstrates Potent and Selective Activity in HER2-low and T-DM1–resistant Breast and Gastric Cancers
Lillian Skidmore, Sukumar Sakamuri, Nick Knudsen et al. · Molecular Cancer Therapeutics · 2020 · 151 citations
Discovery of Pyrophosphate Diesters as Tunable, Soluble, and Bioorthogonal Linkers for Site-Specific Antibody–Drug Conjugates
Jeffrey C. Kern, Mark T. Cancilla, Deborah Dooney et al. · Journal of the American Chemical Society · 2016 · 136 citations
In Vitro and In Vivo Evaluation of Cysteine and Site Specific Conjugated Herceptin Antibody-Drug Conjugates
Dowdy Jackson, John Atkinson, Claudia Guevara et al. · PLoS ONE · 2014 · 119 citations · Full text
Medicinal Chemistry, Drug Target, Anti-her2 Adcs +13
Novel Phosphate Modified Cathepsin B Linkers: Improving Aqueous Solubility and Enhancing Payload Scope of ADCs
Jeffrey C. Kern, Deborah Dooney, Rena Zhang et al. · Bioconjugate Chemistry · 2016 · 89 citations
1–5 of 9